You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer

 

Online download statistics by month:

Online download statistics by month: September 2022 to February 2026

AbstractFullPdf
Sep 2022535562118
Oct 202225125476
Nov 202216216668
Dec 202214915152
Jan 2023989923
Feb 202310711056
Mar 2023888931
Apr 2023606026
May 2023586028
Jun 2023505219
Jul 2023696930
Aug 2023696925
Sep 2023606131
Oct 2023878742
Nov 2023606125
Dec 2023656631
Jan 2024585933
Feb 2024969646
Mar 2024888983
Apr 2024747434
May 2024616320
Jun 2024616034
Jul 2024646537
Aug 20244443168
Sep 2024505123
Oct 2024444428
Nov 2024596040
Dec 2024424325
Jan 2025515132
Feb 2025383819
Mar 2025717165
Apr 2025646535
May 2025394028
Jun 2025434426
Jul 2025110
Sep 2025110
Feb 2026110
Total301830751457